Trump Administration Releases New COVID-19 Vaccine Plan
Digest more
The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.
Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...
The new "regulatory framework for COVID-19 vaccination" laid out by the FDA's new leadership under Health ... ahead of a key meeting of the agency's outside vaccine advisers this Thursday, to ...
Typically, FDA leadership waits until ... Insurance coverage of future COVID vaccines will likely be determined based on recommendations from the CDC and the agency’s independent panel of ...
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research,
More & Johnson COVID-19 vaccine on March 6, 2021 in Thornton, Colorado. FDA Commissioner Marty Makary and Vinay Prasad, the agency’s top vaccine regulator, said in an article published in the ...